Articles with public access mandates - Michael RafiiLearn more
Not available anywhere: 5
Targeting tau protein in Alzheimer's disease
MS Rafii
The lancet 388 (10062), 2842-2844, 2016
Mandates: US National Institutes of Health
Improving memory and cognition in individuals with Down syndrome
MS Rafii
CNS drugs 30, 567-573, 2016
Mandates: US National Institutes of Health
The search for Alzheimer disease therapeutics—same targets, better trials?
MS Rafii, PS Aisen
Nature Reviews Neurology 16 (11), 597-598, 2020
Mandates: US National Institutes of Health
Addressing challenges in health care and research for people with Down syndrome
J Fortea, E McGlinchey, JM Espinosa, MS Rafii
The Lancet 403 (10439), 1830-1833, 2024
Mandates: European Commission
MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population
LEM Wisse, N Spotorno, M Rossi, MJ Grothe, A Mammana, P Tideman, ...
JAMA neurology, 2024
Mandates: Knut and Alice Wallenberg Foundation, European Commission
Available somewhere: 63
Down syndrome
SE Antonarakis, BG Skotko, MS Rafii, A Strydom, SE Pape, DW Bianchi, ...
Nature Reviews Disease Primers 6 (1), 9, 2020
Mandates: Swiss National Science Foundation, US National Institutes of Health, UK …
Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial
S Craft, R Raman, TW Chow, MS Rafii, CK Sun, RA Rissman, ...
JAMA neurology 77 (9), 1099-1109, 2020
Mandates: US National Institutes of Health
Recent developments in Alzheimer's disease therapeutics
MS Rafii, PS Aisen
BMC medicine 7, 1-4, 2009
Mandates: US National Institutes of Health
A phase II trial of huperzine A in mild to moderate Alzheimer disease
MS Rafii, S Walsh, JT Little, K Behan, B Reynolds, C Ward, S Jin, ...
Neurology 76 (16), 1389-1394, 2011
Mandates: US National Institutes of Health
Adeno-associated viral vector (serotype 2)–nerve growth factor for patients with alzheimer disease: a randomized clinical trial
MS Rafii, MH Tuszynski, RG Thomas, D Barba, JB Brewer, RA Rissman, ...
JAMA neurology 75 (7), 834-841, 2018
Mandates: US National Institutes of Health
A phase 3 trial of IV immunoglobulin for Alzheimer disease
NR Relkin, RG Thomas, RA Rissman, JB Brewer, MS Rafii, CH Van Dyck, ...
Neurology 88 (18), 1768-1775, 2017
Mandates: US National Institutes of Health
Alzheimer's disease associated with Down syndrome: a genetic form of dementia
J Fortea, SH Zaman, S Hartley, MS Rafii, E Head, M Carmona-Iragui
The Lancet Neurology 20 (11), 930-942, 2021
Mandates: US National Institutes of Health, Government of Spain
High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment
S Kovacevic, MS Rafii, JB Brewer, ...
Alzheimer Disease & Associated Disorders 23 (2), 139-145, 2009
Mandates: US National Institutes of Health
Outcome measures for clinical trials in Down syndrome
AJ Esbensen, SR Hooper, D Fidler, SL Hartley, J Edgin, XL d'Ardhuy, ...
American journal on intellectual and developmental disabilities 122 (3), 247-281, 2017
Mandates: US National Institutes of Health, US Department of Education
Advances in Alzheimer’s disease drug development
MS Rafii, PS Aisen
BMC medicine 13 (1), 62, 2015
Mandates: US National Institutes of Health
Effect of AZD0530 on cerebral metabolic decline in Alzheimer disease: a randomized clinical trial
CH Van Dyck, HB Nygaard, K Chen, MC Donohue, R Raman, ...
JAMA neurology 76 (10), 1219-1229, 2019
Mandates: US National Institutes of Health
Trial of solanezumab in preclinical Alzheimer’s disease
RA Sperling, MC Donohue, R Raman, MS Rafii, K Johnson, CL Masters, ...
New England Journal of Medicine 389 (12), 1096-1107, 2023
Mandates: US National Institutes of Health
The AHEAD 3‐45 Study: design of a prevention trial for Alzheimer's disease
MS Rafii, RA Sperling, MC Donohue, J Zhou, C Roberts, MC Irizarry, ...
Alzheimer's & dementia 19 (4), 1227-1233, 2023
Mandates: US National Institutes of Health
PET imaging of tau pathology and relationship to amyloid, longitudinal MRI, and cognitive change in Down syndrome: results from the Down Syndrome Biomarker Initiative (DSBI)
MS Rafii, AS Lukic, RD Andrews, J Brewer, RA Rissman, SC Strother, ...
Journal of Alzheimer's Disease 60 (2), 439-450, 2017
Mandates: US National Science Foundation, US Department of Defense, US National …
Further understanding the connection between Alzheimer's disease and Down syndrome
HM Snyder, LJ Bain, AM Brickman, MC Carrillo, AJ Esbensen, ...
Alzheimer's & Dementia 16 (7), 1065-1077, 2020
Mandates: US National Institutes of Health, Alzheimers's UK, UK Medical Research …
Publication and funding information is determined automatically by a computer program